• 제목/요약/키워드: R&D of new drug

검색결과 79건 처리시간 0.025초

약제내성 결핵균의 검출을 위한 Oligonucleotide Chip의 개발 (Development of Oligonucleotide Chip for Detection of Drug-Resistant Mycobacterium Tuberculosis)

  • 송은실;박희경;장현정;김효명;장철훈;김철민
    • Tuberculosis and Respiratory Diseases
    • /
    • 제55권1호
    • /
    • pp.41-58
    • /
    • 2003
  • 연구배경 : 약제내성 결핵권의 조기 진단을 위해서, 최근 돌연변이 검출 및 질병의 진단 등에 새로운 기술로 대두되고 있는 올리고뉴콜레오티드 칩 기술을 이용하여 결핵균의 리팜핀, 아이소나아지드와 스트렙토마이신 내성과 관련된 rpoB, katG와 rpsL 유전자의 주요 돌연변이를 신속하고 정확하게 검출하고자 하였다. 방 법 : 리팜핀 내성 검출의 야생형 7개와 돌연변이형 13개, 아이소니아지드 내성 검출의 야생형 2개와 돌연변이형 3개, 그리고 스트렙토마이신 내성 검출을 위한 야생형과 돌연변이형 프로브 각 2종류를 고안한 후, 유리 슬라이드에 고정시켜 올리고뉴클레오티드 칩을 제작하였고, 약제내성을 가지고 있는 배양균주 55균주를 선택하여 PCR 증폭반응과 혼성화 반응을 실시한 후 비공초점 레이저 스케너를 이용하여 돌연변이를 검출하였다. 이를 염기서열방법으로 확인하여 돌연변이 다형성을 분석하였다. 결 과 : 리팜핀 내성은 코돈 531과 코돈 526에서 65%의 돌연변이를 검출하였고, 현재까지 보고되어 있지 않은 D516F의 새로운 돌연변이도 검출하였다. 아이소니아지드 내성은 S315T와 R463L 돌연변이가 45.2%로 검출되었고, 스트렙토마이신 내성은 K43R과 K88R 돌연변이가 78%로 검출되었다. 리팜핀 내성의 88%(35/40), 아이소니아지드 내성의 50%(20/42), 그리고 스트렙토마이신 내성의 78%(7/9)를 검출함으로써 현재까지 보고되어 있는 세가지 약제내성과 관련된 rpoB, katG와 rpsL 유전자의 주요 돌연변이는 대부분 검출할 수 있음을 확인할 수 있었고, 염기서열분석 결과와 비교하였을 때 모두 일치하는 결과를 얻음으로써 올리고뉴콜레오티드 칩의 유용성을 확인할 수 있었다. 결 론 : 따라서 본 연구에서 개발한 올라고뉴클레오티드 칩은 약재내성 결핵균의 조기 진단에 유용한 도구가 될 것으로 사료된다.

Modeling and Simulation of Scheduling Medical Materials Using Graph Model for Complex Rescue

  • Lv, Ming;Zheng, Jingchen;Tong, Qingying;Chen, Jinhong;Liu, Haoting;Gao, Yun
    • Journal of Information Processing Systems
    • /
    • 제13권5호
    • /
    • pp.1243-1258
    • /
    • 2017
  • A new medical materials scheduling system and its modeling method for the complex rescue are presented. Different from other similar system, first both the BeiDou Satellite Communication System (BSCS) and the Special Fiber-optic Communication Network (SFCN) are used to collect the rescue requirements and the location information of disaster areas. Then all these messages will be displayed in a special medical software terminal. After that the bipartite graph models are utilized to compute the optimal scheduling of medical materials. Finally, all these results will be transmitted back by the BSCS and the SFCN again to implement a fast guidance of medical rescue. The sole drug scheduling issue, the multiple drugs scheduling issue, and the backup-scheme selection issue are all utilized: the Kuhn-Munkres algorithm is used to realize the optimal matching of sole drug scheduling issue, the spectral clustering-based method is employed to calculate the optimal distribution of multiple drugs scheduling issue, and the similarity metric of neighboring matrix is utilized to realize the estimation of backup-scheme selection issue of medical materials. Many simulation analysis experiments and applications have proved the correctness of proposed technique and system.

Electrooxidation of Zolpidem and its Voltammetric Quantification in Standard and Pharmaceutical Formulation using Pencil Graphite Electrode

  • Naeemy, A.;Sedighi, E.;Mohammadi, A.
    • Journal of Electrochemical Science and Technology
    • /
    • 제7권1호
    • /
    • pp.68-75
    • /
    • 2016
  • In this study a new, simple, precise, accurate and economic electrochemical method was developed and validated for the voltammetric determination of zolpidem (ZP) using disposable pencil graphite (PG) electrode. The anodic oxidation of ZP on the surface of the PG electrode was examined in a britton robinson (BR) buffer. Square wave and cyclic voltammetry were used as electrochemical techniques in the potential range of 0-1.2 V in the pH 8 BR buffer. In cyclic voltammetry studies, the diffusion coefficient of ZP oxidation was found to be 3.6×10-6 cm2 s-1. On the other hand, the ZP has shown a well-defined irreversible anodic peak at 0.98 V in the square wave voltammetry mode. The PG electrode, primarily being graphite which has a large active surface area gives rise to increasing peak current with respect to ZP electrooxidation. PG electrode showed an electrocatalytic effect in anodic oxidation of ZP. A linear relationship between catalytic current response and ZP concentration was obtained over a concentration range of 10-30 μM with R.S.D. values ranging from 0.29-3.89. Limits of detection and quantitation were found to be 1 and 3 μM, respectively. Finally, the PG electrode was successfully used to determine ZP in standard and tablet dosage forms with a mean recovery of 100.69 %.

DNA Structural Perturbation Induced by the CPI-Derived DNA Interstrand Cross-linker : Molecular Mechanisms for the Sequence Specific Recognition

  • Park, Hyun-Ju
    • Archives of Pharmacal Research
    • /
    • 제24권5호
    • /
    • pp.455-465
    • /
    • 2001
  • The highly potent cytotoxic DNA-DNA cross-linker consists of two cyclopropa[c]pyrrolo[3,4-3]indol-4(5H)-ones insoles [(+)-CPI-I] joined by a bisamido pyrrole (abbreviated to "Pyrrole"). The Pyrrole is a synthetic analog of Bizelesin, which is currently in phase II clinical trials due to its excellent in vivo antitumor activity. The Pyrrole has 10 times more potent cytotoxicity than Bizelesin and mostly form DNA-DNA interstrand cross-links through the N3 of adenines spaced 7 bp apart. The Pyrrole requires a centrally positioned GC base pair for high cross-linking reactivity (i.e., $5^1$-T$AT_2$A*-$3^1$), while Bizelesin prefers purely AT-rich sequences (i.e., $5^1$-T$AT_4$A*-$3^1$, where /(equation omitted) represents the cross-strand adenine alkylation and A* represents an adenine alkylation) (Park et al., 1996). In this study, the high-field $^1$H-NMR and rMD studies are conducted on the 1 1-mer DNA duplex adduct of the Pyrrole where the 5′(equation omitted)TAGTTA*-3′sequence is cross-linked by the drug. A severe structural perturbation is observed in the intervening sequences of cross-linking site, while a normal B-DNA structure is maintained in the region next to the drug-modified adenines. Based upon these observations, we propose that the interplay between the bisamido pyrrole unit of the drug and central C/C base pair (hydrogen-bonding interactions) is involved in the process of cross-linking reaction, and sequence specificity is the outcome of those interactions. This study suggests a mechanism for the sequence specific cross-linking reaction of the Pyrrole, and provides a further insight to develop new DNA sequence selective and distortive cross-linking agents.

  • PDF

엔젤투자자의 투자의사 결정요인 분석: 재무적 특성을 중심으로 (The Analysis of Investment Determinants in Angel Investors: Focus on the Financial Characteristics)

  • 이상창;임병권;김천규
    • 벤처창업연구
    • /
    • 제18권6호
    • /
    • pp.147-157
    • /
    • 2023
  • 최근 벤처기업 육성을 위한 제2벤처 붐 확산 등에 힘입어 전문투자자 뿐만 아니라 일반 개인까지 스타트업 시장에 대한 관심이 증가하고 있다. 이와 같은 투자자 다변화에 따라 최근 엔젤투자자를 대상으로 다양한 연구가 진행되고 있으나 그들의 투자기업 선정 시 어떠한 요인을 고려하는지에 대해서는 주로 설문조사를 기반으로 연구가 이루어진 상황이다. 따라서 엔젤투자자가 실제로 투자한 기업내역을 토대로 그들이 어떠한 기업특성을 고려하는지에 대해 보다 엄정하게 고찰할 필요가 있다. 본 연구는 첫쨰, 엔젤투자자의 투자결정에 있어 어떠한 재무적 특성이 영향을 미치는지를 분석하였다. 둘째, 스타트업의 업력을 기준으로 창업 초기 또는 창업 중기단계 이후의 기업을 구분한 후 세부적인 분석을 수행하였다. 본 연구의 주요 분석결과를 요약하면 다음과 같다. 첫째, 엔젤투자자의 투자기업 선정에 있어 수익성이나 안정성보다는 순이익증가율이나 자산증가율과 같은 성장성 측면이 중요한 요인으로 작용하였다. 또한, 무형자산과 R&D 비중이 높을수록 투자기업을 선택할 가능성이 높은 것으로 확인된다. 둘째, 엔젤투자자의 투자기업 선정을 위한 재무적 요인에 있어 업력이 3년을 초과하여 본격적으로 창업 중기단계에 진입한 기업에서는 성장성 뿐만 아니라 활동성 측면도 투자결정에 영향을 미치는 것으로 나타났다. 종합하면, 엔젤투자자의 투자의사 결정은 기 실현된 수익성 보다는 스타트업의 성장세나 향후 성장 가능성에 중점을 두고 행해지는 것으로 판단된다. 또한, 창업 중기 이후의 기업은 성장성과 함께 실질적인 성과창출 가능성도 중요한 투자결정 요인인 것으로 추론해 볼 수 있다. 본 연구는 엔젤투자자가 실제로 투자한 내역을 기초로 다양한 스타트업의 재무적 특성을 고려하여 그들의 투자결정에 어떠한 측면이 중요하게 작용하는지를 실증적으로 규명하였다는 점에서 연구의 의의가 있다.

  • PDF

High Performance Liquid Chromatographic Analysis of a New Proton Pump Inhibitor KR60436 and Its Active Metabolite O-Demethyl-KR60436 in Rat Plasma Samples Using Column-Switching

  • Lee, Hyun-Mee;Lee, Hee-Yong;Choi, Joong-Kwon;Lee, Hye-Suk
    • Archives of Pharmacal Research
    • /
    • 제24권3호
    • /
    • pp.207-210
    • /
    • 2001
  • A fully automated high performance liquid chromatography with column-switching was developed for the simultaneous determination of KR60436, a new reversible proton pump inhibitor, and its active metabolite O-Demethyl-KR60436 from rat plasma samples. Plasma sample (50$\mu$l) was directly introduced onto a Capcell Pak MF Ph-1 column ($10{\times}4$ mm I.D.) where primary separation was occurred to remove proteins and concentrate target Substances Using acetonitrile-Potassium Phosphate (PH 7, 0.1 M) (2 : 8, v/v). The drug molecules eluted from MF Ph-1 column were focused in an intermediate column ($10{\times}2$ I.D.) by the valve switching step. The substances enriched in intermediate column were eluted and separated on a Vydac 218MR53 column ($250{\times}3.2$ I.D.) using acetonitrilepotassium phosphate (pH 7, 0.02 M) (47:53, v/v) at a flow rate of 0.5 ml/min when the valve status was switched back to A position. The method showed excellent sensitivity (detection limit of 2 ng/ml) with small volume of samples ($50{\mu}$l), good precision and accuracy, and speed (total analysis time 24 min) without any loss in chromatographic efficiency. The response was linear ($r^2{\geq}0.797$) over the concentration range of 5-500 ng/ml.

  • PDF

An International Collaborative Program To Discover New Drugs from Tropical Biodiversity of Vietnam and Laos

  • Soejarto, Djaja D.;Pezzuto, John M.;Fong, Harry H.S.;Tan, Ghee Teng;Zhang, Hong Jie;Tamez, Pamela;Aydogmus, Zeynep;Chien, Nguyen Quyet;Franzblau, Scott G.;Gyllenhaal, Charlotte;Regalado, Jacinto C.;Hung, Nguyen Van;Hoang, Vu Dinh;Hiep, Nguyen Tien;Xuan, Le Thi;Hai, Nong Van;Cuong, Nguyen Manh;Bich, Truong Quang;Loc, Phan Ke;Vu, Bui Minh;Southavong, Boun Hoong
    • Natural Product Sciences
    • /
    • 제8권1호
    • /
    • pp.1-15
    • /
    • 2002
  • An International Cooperative Biodiversity Group (ICBG) program based at the University of Illinois at Chicago initiated its activities in 1998, with the following specific objectives: (a) inventory and conservation of of plants of Cuc Phuong National Park in Vietnam and of medicinal plants of Laos; (b) drug discovery (and development) based on plants of Vietnam and Laos; and (c) economic development of communities participating in the ICBG project both in Vietnam and Laos. Member-institutions and an industrial partner of this ICBG are bound by a Memorandum of Agreement that recognizes property and intellectual property rights, prior informed consent for access to genetic resources and to indigenous knowledge, the sharing of benefits that may arise from the drug discovery effort, and the provision of short-term and long-term benefits to host country institutions and communities. The drug discovery effort is targeted to the search for agents for therapies against malaria (antimalarial assay of plant extracts, using Plasmodium falciparum clones), AIDS (anti-HIV-l activity using HOG.R5 reporter cell line (through transactivation of the green fluorescent protein/GFP gene), cancer (screening of plant extracts in 6 human tumor cell lines - KB, Col-2, LU-l, LNCaP, HUVEC, hTert-RPEl), tuberculosis (screening of extracts in the microplate Alamar Blue assay against Mycobacterium tuberculosis $H_{37}Ra\;and\;H_{37}Rv),$ all performed at UIC, and CNS-related diseases (with special focus on Alzheimer's disease, pain and rheumatoid arthritis, and asthma), peformed at Glaxo Smith Kline (UK). Source plants were selected based on two approaches: biodiversity-based (plants of Cuc Phuong National Park) and ethnobotany-based (medicinal plants of Cuc Phuong National Park in Vietnam and medicinal plants of Laos). At mc, as of July, 2001, active leads had been identified in the anti-HIV, anticancer, antimalarial, and anti- TB assay, after the screening of more than 800 extracts. At least 25 biologically active compounds have been isolated, 13 of which are new with anti-HIV activity, and 3 also new with antimalarial activity. At GSK of 21 plant samples with a history of use to treat CNS-related diseases tested to date, a number showed activity against one or more of the CNS assay targets used, but no new compounds have been isolated. The results of the drug discovery effort to date indicate that tropical plant diversity of Vietnam and Laos unquestionably harbors biologically active chemical entities, which, through further research, may eventually yield candidates for drug development. Although the substantial monetary benefit of the drug discovery process (royalties) is a long way off, the UIC ICBG program provides direct and real-term benefits to host country institutions and communities.

Keratinocyte Migration in a Three-Dimensional In Vitro Wound Healing Model Co-Cultured with Fibroblasts

  • Iyer, Kritika;Chen, Zhuo;Ganapa, Teja;Wu, Benjamin M.;Tawil, Bill;Linsley, Chase S.
    • Tissue Engineering and Regenerative Medicine
    • /
    • 제15권6호
    • /
    • pp.721-733
    • /
    • 2018
  • BACKGROUND: Because three-dimensional (3D) models more closely mimic native tissues, one of the goals of 3D in vitro tissue models is to aid in the development and toxicity screening of new drug therapies. In this study, a 3D skin wound healing model comprising of a collagen type I construct with fibrin-filled defects was developed. METHODS: Optical imaging was used to measure keratinocyte migration in the presence of fibroblasts over 7 days onto the fibrin-filled defects. Additionally, cell viability and growth of fibroblasts and keratinocytes was measured using the $alamarBlue^{(R)}$ assay and changes in the mechanical stiffness of the 3D construct was monitored using compressive indentation testing. RESULTS: Keratinocyte migration rate was significantly increased in the presence of fibroblasts with the cells reaching the center of the defect as early as day 3 in the co-culture constructs compared to day 7 for the control keratinocyte monoculture constructs. Additionally, constructs with the greatest rate of keratinocyte migration had reduced cell growth. When fibroblasts were cultured alone in the wound healing construct, there was a 1.3 to 3.4-fold increase in cell growth and a 1.2 to 1.4-fold increase in cell growth for keratinocyte monocultures. However, co-culture constructs exhibited no significant growth over 7 days. Finally, mechanical testing showed that fibroblasts and keratinocytes had varying effects on matrix stiffness with fibroblasts degrading the constructs while keratinocytes increased the construct's stiffness. CONCLUSION: This 3D in vitro wound healing model is a step towards developing a mimetic construct that recapitulates the complex microenvironment of healing wounds and could aid in the early studies of novel therapeutics that promote migration and proliferation of epithelial cells.

Evidence for a Common Molecular Basis for Sequence Recognition of N3-Guanine and N3-Adenine DNA Adducts Involving the Covalent Bonding Reaction of (+)-CC-1065

  • Park, Hyun-Ju
    • Archives of Pharmacal Research
    • /
    • 제25권1호
    • /
    • pp.11-24
    • /
    • 2002
  • The antitumor antibiotic (+)-CC-1065 can alkylate N3 of guanine in certain sequences. A previous high-field $^1H$ NMR study on the$(+)-CC-1065d[GCGCAATTG*CGC]_2$ adduct ($^*$ indicates the drug alkylation site) showed that drag modification on N3 of guanine results in protonation of the cross-strand cytosine [Park, H-J.; Hurley, L. H. J. Am. Chem. Soc.1997, 119,629]. In this contribution we describe a further analysis of the NMR data sets together with restrained molecular dynamics. This study provides not only a solution structure of the (+)-CC-1065(N3- guanine) DNA duplex adduct but also new insight into the molecular basis for the sequence- specific interaction between (+)-CC-1065 and N3-guanine in the DNA duplex. On the basis of NOESY data, we propose that the narrow minor groove at the 7T8T step and conformational kinks at the junctions of 16C17A and 18A19T are both related to DNA bending in the drugDNA adduct. Analysis of the one-dimensional $^1H$ NMR (in $H_2O$) data and rMD trajectories strongly suggests that hydrogen bonding linkages between the 8-OH group of the (+)-CC-1065 A-sub-unit and the 9G10C phosphate via a water molecule are present. All the phenomena observed here in the (+)-CC-1065(N3-guanine) adduct at 5'$-AATTG^*$are reminiscent of those obtained from the studies on the (+)-CC-1065(N3-adenine) adduct at $5'-AGTTA^*$, suggesting that (+)-CC-1065 takes advantage of the conformational flexibility of the 5'-TPu step to entrap the bent structure required for the covalent bonding reaction. This study reveals a common molecular basis for (+)-CC-1065 alkylation at both $5'-TTG^*$ and $5'-TTA^*$, which involves a trapping out of sequence-dependent DNA conformational flexibility as well as sequence-dependent general acid and general base catalysis by duplex DNA.

Development of a Zebrafish Larvae Model for Diabetic Heart Failure With Reduced Ejection Fraction

  • Inho Kim;Seung Hyeok Seok;Hae-Young Lee
    • Korean Circulation Journal
    • /
    • 제53권1호
    • /
    • pp.34-46
    • /
    • 2023
  • Background and Objectives: Diabetes mellitus (DM)-associated heart failure (HF) causes high morbidity and mortality. In this study, we established a zebrafish larvae model for in vivo research on diabetic HF. Methods: DM-like phenotypes were induced by treating zebrafish larvae with a combination of D-glucose (GLU) and streptozotocin (STZ). HF was induced by treatment with terfenadine (TER), a potassium channel blocker. Additionally, myocardial contractility, motility, and viability were evaluated. Results: The zebrafish larvae treated with a combination of GLU and STZ showed significantly higher whole-body glucose concentrations, lower insulin levels, and higher phosphoenolpyruvate carboxykinase levels, which are markers of abnormal glucose homeostasis, than the group treated with only GLU, with no effect on viability. When treated with TER, DM zebrafish showed significantly less myocardial fractional shortening and more irregular contractions than the non-DM zebrafish. Furthermore, in DM-HF with reduced ejection fraction (rEF) zebrafish, a significant increase in the levels of natriuretic peptide B, a HF biomarker, markedly reduced motility, and reduced survival rates were observed. Conclusions: We established a DM-HFrEF zebrafish model by sequentially treating zebrafish larvae with GLU, STZ, and TER. Our findings indicate the potential utility of the developed zebrafish larvae model not only in screening studies of new drug candidates for DM-HFrEF but also in mechanistic studies to understand the pathophysiology of DM-HFrEF.